Vontobel Holding Ltd. Sells 13,868 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Vontobel Holding Ltd. decreased its position in Teladoc Health, Inc. (NYSE:TDOC) by 48.7% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 14,615 shares of the health services provider’s stock after selling 13,868 shares during the quarter. Vontobel Holding Ltd.’s holdings in Teladoc Health were worth $134,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Teladoc Health by 2.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 65,588 shares of the health services provider’s stock worth $641,000 after acquiring an additional 1,352 shares during the period. Covestor Ltd raised its stake in shares of Teladoc Health by 58.1% during the 1st quarter. Covestor Ltd now owns 3,817 shares of the health services provider’s stock worth $57,000 after purchasing an additional 1,403 shares during the period. Westside Investment Management Inc. boosted its holdings in shares of Teladoc Health by 37.7% in the 1st quarter. Westside Investment Management Inc. now owns 5,662 shares of the health services provider’s stock worth $85,000 after buying an additional 1,550 shares during the last quarter. Signaturefd LLC grew its position in Teladoc Health by 148.7% during the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after buying an additional 1,715 shares during the period. Finally, Swiss National Bank increased its holdings in Teladoc Health by 0.6% during the first quarter. Swiss National Bank now owns 326,902 shares of the health services provider’s stock worth $4,936,000 after buying an additional 1,800 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Insider Activity

In other news, CMO Stephany Verstraete sold 15,000 shares of the stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $7.60, for a total transaction of $114,000.00. Following the completion of the sale, the chief marketing officer now directly owns 45,158 shares in the company, valued at approximately $343,200.80. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, CEO Laizer Kornwasser sold 10,879 shares of the stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $8.14, for a total value of $88,555.06. Following the completion of the transaction, the chief executive officer now directly owns 99,929 shares in the company, valued at $813,422.06. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CMO Stephany Verstraete sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $7.60, for a total value of $114,000.00. Following the completion of the sale, the chief marketing officer now directly owns 45,158 shares in the company, valued at approximately $343,200.80. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 57,377 shares of company stock valued at $438,054. 0.95% of the stock is currently owned by company insiders.

Teladoc Health Price Performance

Shares of NYSE:TDOC opened at $8.66 on Thursday. Teladoc Health, Inc. has a one year low of $6.76 and a one year high of $22.54. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.62. The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of -6.14 and a beta of 0.91. The company’s fifty day moving average price is $8.24 and its 200-day moving average price is $9.92.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.36) by $0.08. The firm had revenue of $642.44 million during the quarter, compared to analyst estimates of $649.34 million. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. On average, equities research analysts anticipate that Teladoc Health, Inc. will post -1.18 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on TDOC. Stifel Nicolaus reduced their target price on shares of Teladoc Health from $16.00 to $9.00 and set a “hold” rating for the company in a research report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft reduced their price objective on Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a report on Friday, August 2nd. Cantor Fitzgerald reissued an “overweight” rating and issued a $10.00 price objective on shares of Teladoc Health in a report on Tuesday, August 20th. Oppenheimer cut their target price on shares of Teladoc Health from $21.00 to $17.00 and set an “outperform” rating for the company in a research report on Thursday, August 1st. Finally, Royal Bank of Canada upped their price target on shares of Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a research note on Wednesday, October 9th. Fifteen equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $11.81.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.